Stock ATRINSIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Atrinsic, Inc. Other OTC

Equities

US04964C2089

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Atrinsic, Inc.
05-01 Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial CI
04-01 Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Group Starts Protagenic Therapeutics at Buy with $4 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTIX Stock
  4. Stock
  5. News Atrinsic, Inc.
  6. Analyst Reco.